
New Perspectives on the Risk of Secondary Cancers After CAR T-cell Therapy
Amidst an FDA investigation into secondary cancers after CAR T therapy, researchers show the risk is likely minimal.
Amidst an FDA investigation into secondary cancers after CAR T therapy, researchers show the risk is likely minimal.
Expanding clinical trial eligibility requirements can help increase participation and more accurately show how treatments work in a real-world...
This quarter's round-up of cutting-edge cancer research includes a way to fight chemo brain, controlling cancer cell death, and...
Clinical trials for dogs with cancer can extend the lives of our four-legged friends while revealing insights about cancer...
At a recent AACR Special Conference, experts discussed emerging therapeutic options to overcome resistance to Bacillus Calmette-Guérin (BCG).
Researchers around the world are designing and implementing methods to increase access to cancer care in low-resource areas.
The closing plenary of the AACR Annual Meeting 2024 recapped basic science, prevention, clinical advances, and more.
The latest installment of this quarterly series highlights innovative research approaches reported at the AACR Annual Meeting 2024.
A plenary session at the AACR Annual Meeting 2024 explored how metastases adapt to—and help shape—their new environments.
The AACR Annual Meeting 2024 Opening Plenary showed how researchers are inspiring science, fueling progress, and revolutionizing care.